Cargando…
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at doses of 60 mg daily. Duloxetine has been shown to significantly improve the symptoms of chronic pain associated with these...
Autores principales: | Wright, Alan, Luedtke, Kyle E, VanDenBerg, Chad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048581/ https://www.ncbi.nlm.nih.gov/pubmed/21386950 http://dx.doi.org/10.2147/JPR.S12866 |
Ejemplares similares
-
Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009) -
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials
por: Sultan, Asquad, et al.
Publicado: (2008) -
Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009) -
Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy
por: Shahid, Wajeeha, et al.
Publicado: (2019) -
Duloxetine in the management of diabetic peripheral neuropathic pain
por: Ormseth, Michelle J, et al.
Publicado: (2011)